Skip to main content

Effect of a Suicide Substrate on the Metabolism of Steroids and Xenobiotics and on Cytochrome P-450 Apoproteins

  • Chapter
Biological Reactive Intermediates III

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 197))

  • 289 Accesses

Abstract

Xenobiotic administration can significantly alter forms of hepatic microsomal cytochrome P-450. Individual forms of cytochrome P-450 are known to be increased by agents, such as phenobarbital, 3-methylcholanthrene, β-naphthoflavone and pregnenolone-16α-carbonitrile1–3. Certain chemicals decrease the levels of these isoenzymes by modulating the heme biosynthetic pathway and, thereby, affect the availability of heme and the amount of hepatic cytochrome P-450, e.g. cobaltous chloride4,5. Some agents can act as suicide substrates (i.e., mechanism-based inhibitors) for one or more cytochrome P-450 forms and, thereby, promote catabolic destruction of these cytochrome P-450 species6,7. Derivatives of 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) interact rapidly with cytochrome P-450, promote the rapid destruction of hepatic microsomal cytochrome P-450 and lead to the generation in vivo of N-alkyl protoporphyrins which, in turn, inhibit the activity of mitochondrial ferrochelatase, the enzyme catalyzing the last step in heme biosynthesis8–11. The result is a decreased total hepatic microsomal cytochrome P-450 level and a marked hepatic porphyria12,13.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. F. P. Guengerich, Separation and purification of multiple forms of microsomal cytochrome P-450, J. Biol. Chem. 252: 3970 (1977).

    PubMed  CAS  Google Scholar 

  2. D. E. Ryan, P. E. Thomas, D. Korzeniowski and W. Levin, Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene, J. Biol. Chem. 254: 1365 (1979).

    PubMed  CAS  Google Scholar 

  3. F. P. Guengerich, G. A Dannan, S. T. Wright, M. V. Martin and L. S. Kaminsky, Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or ß-naphthoflavone, Biochemistry 21: 6019 (1982).

    Article  PubMed  CAS  Google Scholar 

  4. T. R. Tephly and P. Hibbeln, The effect of cobalt chloride administration on the synthesis of hepatic microsomal cytochrome P-450, Biochem. Biophys. Res. Commun. 42: 589 (1971).

    Article  PubMed  CAS  Google Scholar 

  5. T. R. Tephly, C. R. Webb, P. Trussler, F. Kniffen, E. Hasegawa and W. Piper, The regulation of heure synthesis related to drug metabolism, Drug Metab. Dispos. 1: 259 (1973).

    PubMed  CAS  Google Scholar 

  6. P. R. Ortiz de Montellano and B. A. Mico, Destruction of cytochrome P-450 by allylisopropylacetamide is a suicidal process, Arch. Biochem. Biophys. 206: 43 (1981).

    Article  PubMed  CAS  Google Scholar 

  7. H. H. Liem, E. F. Johnson and U. Müller-Eberhard, The effect in vivo and in vitro of allylisopropylacetamide on the content of hepatic microsomal cytochrome P-450 2 of phenobarbital treated rabbits, Biochem. Biophys. Res. Commun. 111: 926 (1983).

    Article  PubMed  CAS  Google Scholar 

  8. F. DeMatteis, A. H. Gibbs and T. R. Tephly, Inhibition of protohaem ferrolyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor, Biochem. J. 188: 145 (1980).

    CAS  Google Scholar 

  9. T. R. Tephly, A. H. Gibbs, G. Ingall and F. DeMatteis, Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine, J. Int. Biochem. 12: 993 (1980).

    Article  CAS  Google Scholar 

  10. P. R. Ortiz de Montellano, H. S. Beilan and K. L. Kunze, N-methylprotoporphyrin IX: chemical synthesis and indentification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment, Proc. Natl. Acad. Sci. USA 78: 1490 (1981).

    Article  PubMed  CAS  Google Scholar 

  11. T. R. Tephly, B. L. Coffman, G. Ingall, A. Zeit-Har, H. M. Goff, H. D. Tabba and K. M. Smith, Identification of N-methylprotoporphyrin IX in livers of untreated mice and mice treated with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC): Source of the methyl group, Arch. Biochem. Biophys. 212: 120 (1981).

    Article  PubMed  CAS  Google Scholar 

  12. F. DeMatteis, A. H. Gibbs, P. B. Farmer and J. H. Lamb, Liver production of N-alkylated porphyrins caused in mice by treatment with substituted dihydropyridines: evidence that the alkyl group on the pyrrole nitrogen originates from the drug, FEBS Letters, 129: 328 (1981).

    Article  CAS  Google Scholar 

  13. B. L. Coffman, G. Ingall and T. R. Tephly, The formation of N-alkylprotoporphyrin IX and destruction cytochrome P-450 in the liver of rats after treatment with 3,5-diethoxycarbonyl-1,4dihydrocollidine and its 4-ethyl analogue, Arch. Biochem. Biophys. 218: 220 (1982).

    Article  PubMed  CAS  Google Scholar 

  14. F. DeMatteis and B. E. Prior, Experimental hepatic porphyria caused by feeding 3,5-diethoxycarbonyl-1,4-dihydro-2,46,-trimethylpyridine, Biochem. J. 83: 1 (1962).

    Google Scholar 

  15. T. Omura and R. Sato, The carbon monoxide-binding pigment of liver microsomes II solubilization, purification, and properties, J. Biol. Chem. 239: 2370 (1964).

    PubMed  CAS  Google Scholar 

  16. Y. Imai, A. Ito and R. Sato, Evidence for biochemically different types of vesicles in the hepatic microsomal fraction, J. Biochem. 60: 417 (1966).

    PubMed  CAS  Google Scholar 

  17. R. A. Prough, M. D. Burke and R. T. Mayer, Direct fluorometric methods for measuring mixed function oxidase activity, Methods Enzymol. 52: 399 (1978).

    Article  PubMed  Google Scholar 

  18. J. Baron and T. R. Tephly, Effect of 3-amino-1,2,4-triazole on the induction of rat hepatic microsomal oxidases, cytochrome P-450 and NADPH-cytochrome c reductase by phenobarbital, Mol. Pharmacol. 5: 10 (1969).

    PubMed  CAS  Google Scholar 

  19. K. W. Bock, B. Burchell, G. J. Dutton, 0. Hanninen, G. J. Mulder, I. S. Owens, G. Siest and T. R. Tephly, UDP-glucuronyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem. Pharmacol. 32: 953 (1983).

    CAS  Google Scholar 

  20. D. J. Waxman, A. Ko and C. Walsh, Regioselectivity and stereoselectivity of androgen hydroxylations catalysed by cytochrome P-450 isozymes purified from phenobarbital-induced rat Liver, J. Biol. Chem. 258: 11937 (1983).

    PubMed  CAS  Google Scholar 

  21. M. M. Bradford, A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding, Analyt. Biochem. 72: 248 (1976).

    Article  PubMed  CAS  Google Scholar 

  22. K. E. McMartin, G. Martin-Amat, A. B. Makar and T. R. Tephly, Methanol poisoning. V. Role of formate metabolism in the monkey, J. Pharmacol. Exp. Thor. 201: 564 (1977).

    CAS  Google Scholar 

  23. K. A. Black, V. Virayotha and T. R. Tephly, Reductio?4of hepatic tetrahydrofolatg4and inhibition of exhalation of CO2 formed from [dimethylamino- CI-aminopyrine in nitrous oxide-treated rats, Hepatology 4: 871 (1984).

    Article  PubMed  CAS  Google Scholar 

  24. J. T. Eells, A. B. Makar, P. E. Noker and T. R. Tephly, Methanol poisoning and formate oxidation in nitrous oxide treated rats, J. Pharmacol. Exp. Ther. 217: 57 (1981).

    PubMed  CAS  Google Scholar 

  25. K. E. McMartin, V. Virayotha and T. R. Tephly, High-pressure liquid chromatography separation and determination of rat liver folates, Arch. Biochem. Biophys. 209: 127 (1981).

    Article  PubMed  CAS  Google Scholar 

  26. L. S. Kaminsky, M. J. Fasco and F. P. Guengerich, Production and application of antibodies to rat liver cytochrome P-450, Methods Enzymol. 74: 262 (1981).

    Article  PubMed  CAS  Google Scholar 

  27. F. P. Guengerich, P. Wang and N. K. Davidson, Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and humans using immunochemical staining coupled with sodium dodecyl sulfatepolyacrylamide gel electrophoresis, Biochemistry 21: 1698 (1982).

    Article  PubMed  CAS  Google Scholar 

  28. D. Larrey, L. M. Distlerath, G. A. Dannan, G. R. Wilkinson and F. P. Guengerich, F.P. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxytion of debrisoquine, a prototype for genetic variation in oxidative drug metabolism, Biochemistry 23: 2787 (1984).

    Article  PubMed  CAS  Google Scholar 

  29. O. Augusto, H. S. Beilan and P. R. Ortiz de Montellano, The catalytic mechanism of cytochrome P-450. Spin-trapping evidence for one-electron substrate oxidation, J. Biol. Chem. 257: 11288 (1982).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Tephly, T.R., Black, K.A., Green, M.D., Coffman, B.L., Dannan, G.A., Guengerich, F.P. (1986). Effect of a Suicide Substrate on the Metabolism of Steroids and Xenobiotics and on Cytochrome P-450 Apoproteins. In: Kocsis, J.J., Jollow, D.J., Witmer, C.M., Nelson, J.O., Snyder, R. (eds) Biological Reactive Intermediates III. Advances in Experimental Medicine and Biology, vol 197. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5134-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5134-4_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5136-8

  • Online ISBN: 978-1-4684-5134-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics